TP53 is the most frequently mutated gene in human cancer and there are thus numerous, highly curated and independent repositories of TP53 cancer-associated variants available via large-scale tumor genome sequencing projects such as GENIE, TCGA, or ICGC (see Materials and methods for details). This evidence concerns the gene TP53 and cancer.